A one year study by the Washington Post has documented 620 cases in which experimental drugs have been implicated in the deaths of cancer patients....And they amount to merely a fraction of the thousands of people who in recent years have died or suffered terribly from cancer experiments.

The level of trust is extraordinarily low and the level of suspicion extraordinarily high, and with good reason and on both sides. The press has hunkered down for very good reason, because it's being treated like a mushroom.

The press is going to have to learn anew that it's possible to work in an environment that is not so toxic and to readopt those kinds of techniques. The relationship between the press and the Clinton White House during the later period was not a healthy one. There was a lot of hostility and a lot of suspicion. This administration has done systematically what no other administration had done. They came in with a corporate mentality, an ability to stay on script that was without parallel.

You have tens, hundreds of thousands of people in government, and just as many among contractors, who feel totally comfortable writing at the top of the document "internal use only," "official use only," and a million other synonyms, all of which amount to "none of your business" to the public.

It will be important to restore those provisions, those disclose provisions, those release provisions so that presidents are indeed held accountable and their information and papers are made public.

Whistleblowers is another aspect that needs to be addressed. We have to restore the protections of whistleblowers and also the encouragement and rewards. It shouldn't just be that they don't get crucified; it should be that they are again folk heroes, or celebrated for bringing critical matters to public attention, as opposed to traitors.

...In the vast majority of drug experiments, it is not uncommon for none or one or two of hundreds of patients to benefit from the drug.